We are live on
!
Find out more
SELLAS Life Sciences
31 hedge funds and large institutions have $3.73M invested in SELLAS Life Sciences in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
5,170% more call options, than puts
Call options by funds: $2.63M | Put options by funds: $50K
333% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 3
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
11% more funds holding
Funds holding: 28 → 31 (+3)
1.2% more ownership
Funds ownership: 9.76% → 10.96% (+1.2%)
18% less capital invested
Capital invested by funds: $4.54M → $3.73M (-$813K)
Holders
31
Holders Change
+3
Holders Change %
+10.71%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
13
Reduced
3
Closed
5
Calls
$2.63M
Puts
$50K
Net Calls
+$2.58M
Net Calls Change
-$365K
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$887K |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$202K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$119K |
| 4 |
OCG
Opus Capital Group
Cincinnati,
Ohio
|
+$109K |
| 5 |
Bank of New York Mellon
New York
|
+$69.5K |
